Oncocytic mucoepidermoid carcinoma: clinicopathologic description in a series of 12 cases.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 18971778)

Published in Am J Surg Pathol on March 01, 2009

Authors

Ilan Weinreb1, Raja R Seethala, Bayardo Perez-Ordoñez, Runjan Chetty, Aaron P Hoschar, Jennifer L Hunt

Author Affiliations

1: Department of Pathology, University Health Network, University of Toronto, Toronto, Ontario, Canada. weinrebi@yahoo.ca

Articles by these authors

The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Clin Cancer Res (2006) 3.28

Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab (2011) 2.93

Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol (2010) 2.56

Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance". Cancer Cytopathol (2010) 2.55

Primary frozen section diagnosis by robotic microscopy and virtual slide telepathology: the University Health Network experience. Hum Pathol (2009) 2.54

Iatrogenic deep epithelial misplacement ("gastritis cystica profunda") in a gastric foveolar-type adenoma after endoscopic manipulation: a diagnostic pitfall. Am J Surg Pathol (2011) 2.35

First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy. Cancer Discov (2012) 2.31

Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract. Am J Surg Pathol (2007) 2.00

Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol (2012) 1.92

The mutational landscape of adenoid cystic carcinoma. Nat Genet (2013) 1.83

Salivary type tumors seen in consultation. Virchows Arch (2009) 1.79

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer (2014) 1.75

Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands. Histopathology (2012) 1.68

Activation of Notch signaling in human colon adenocarcinoma. Int J Oncol (2008) 1.66

Gastric hyperplastic polyps: a review. Dig Dis Sci (2008) 1.66

Eosinophilic gastroenteritis: a review. J Gastroenterol (2008) 1.63

The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. Am J Surg Pathol (2012) 1.58

HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer. Clin Cancer Res (2009) 1.57

Cribriform adenocarcinoma of minor salivary gland origin principally affecting the tongue: characterization of new entity. Am J Surg Pathol (2011) 1.53

Epithelial-myoepithelial carcinoma with high grade transformation. Am J Surg Pathol (2010) 1.51

EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer (2011) 1.50

Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature. Am J Surg Pathol (2007) 1.50

The pathology milestones and the next accreditation system. Arch Pathol Lab Med (2014) 1.48

Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic. Arch Pathol Lab Med (2004) 1.45

Sinonasal tumors: a clinicopathologic update of selected tumors. Eur Arch Otorhinolaryngol (2012) 1.43

Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys (2006) 1.42

E-cadherin in solid pseudopapillary tumors of the pancreas. Hum Pathol (2008) 1.41

Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma. Arch Pathol Lab Med (2008) 1.40

Clear cell (glycogen rich) gastric adenocarcinoma: a distinct tubulo-papillary variant with a predilection for the cardia/gastro-oesophageal region. Pathology (2007) 1.38

Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer. J Clin Oncol (2010) 1.37

Peripheral nerve sheath tumors of the gastrointestinal tract: a multicenter study of 58 patients including NF1-associated gastric schwannoma and unusual morphologic variants. Virchows Arch (2010) 1.36

Clear cell odontogenic carcinomas show EWSR1 rearrangements: a novel finding and a biological link to salivary clear cell carcinomas. Am J Surg Pathol (2013) 1.36

DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol (2012) 1.34

Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining. Endocr Pathol (2008) 1.34

Nodular fasciitis of the head and neck region: a clinicopathologic description in a series of 30 cases. J Cutan Pathol (2009) 1.32

Selected unusual tumors of the stomach: a review. Int J Surg Pathol (2011) 1.32

Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res (2004) 1.32

Human immunodeficiency virus infection, Bcl-2, p53 protein, and Ki-67 analysis in ocular surface squamous neoplasia. Arch Ophthalmol (2002) 1.31

Tumor suppressor gene alterations in respiratory epithelial adenomatoid hamartoma (REAH): comparison to sinonasal adenocarcinoma and inflamed sinonasal mucosa. Am J Surg Pathol (2006) 1.31

Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3. Carcinogenesis (2009) 1.30

Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. Am J Surg Pathol (2007) 1.26

The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases. Cancer Cytopathol (2012) 1.24

Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Cancer Res (2005) 1.23

Sclerosing angiomatoid nodular transformation of the spleen. Arch Pathol Lab Med (2007) 1.22

A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. Cancer (2011) 1.21

Clear cell carcinoma and clear cell odontogenic carcinoma: a comparative clinicopathologic and immunohistochemical study. Head Neck Pathol (2011) 1.19

The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. Appl Immunohistochem Mol Morphol (2010) 1.19

Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy. J Natl Cancer Inst (2008) 1.19

Surgical margins in head and neck cancer: a contemporary review. Head Neck (2012) 1.19

Basal/myoepithelial cells in chronic sinusitis, respiratory epithelial adenomatoid hamartoma, inverted papilloma, and intestinal-type and nonintestinal-type sinonasal adenocarcinoma: an immunohistochemical study. Arch Pathol Lab Med (2007) 1.18

SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells. Clin Cancer Res (2013) 1.18

KRAS mutation testing in colorectal cancer. Adv Anat Pathol (2009) 1.17

Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis. Mod Pathol (2008) 1.16

Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma. Cancer (2008) 1.15

Low-grade intraductal carcinoma of salivary gland: report of 3 cases with marked apocrine differentiation. Am J Surg Pathol (2006) 1.13

Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma. Clin Cancer Res (2012) 1.12

Nasal chondromesenchymal hamartoma in older children and adults: series and immunohistochemical analysis. Arch Pathol Lab Med (2005) 1.11

Papillary squamous cell carcinoma of the head and neck: a clinicopathologic series. Am J Otolaryngol (2010) 1.11

CD30 and Epstein-Barr virus RNA expression in sclerosing angiomatoid nodular transformation of spleen. Virchows Arch (2007) 1.11

Goblet cell carcinoid tumors of the appendix: An overview. World J Gastrointest Oncol (2010) 1.10

Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma. Cancer Prev Res (Phila) (2010) 1.10

Left-sided sessile serrated polyps/adenomas. Hum Pathol (2013) 1.09

Margin assessment in oral squamous cell carcinoma. Cancer (2013) 1.09

Adrenocortical carcinosarcoma: a case report and review of the literature. Diagn Pathol (2010) 1.08

MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck. Cancer (2010) 1.07

Intercalated duct lesions of salivary gland: a morphologic spectrum from hyperplasia to adenoma. Am J Surg Pathol (2009) 1.06

An informatics supported web-based data annotation and query tool to expedite translational research for head and neck malignancies. BMC Cancer (2009) 1.06

Expression profiling by microarrays in colorectal cancer (Review). Oncol Rep (2005) 1.05

Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance. Immunol Res (2005) 1.05

Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms. J Clin Oncol (2009) 1.04

Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status. Head Neck Pathol (2012) 1.04

Controversial ectopic thyroid: a case report of thyroid tissue in the axilla and benign total thyroidectomy. Thyroid (2005) 1.03

Perivascular epithelioid cell neoplasms (PEComas): four malignant cases expanding the histopathological spectrum and a description of a unique finding. Virchows Arch (2007) 1.03

Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor. Nat Genet (2005) 1.03

Non-small cell neuroendocrine carcinoma of the sinonasal tract and nasopharynx. Report of 2 cases and review of the literature. Head Neck Pathol (2007) 1.02

Chondrosarcomas of the head and neck. Eur Arch Otorhinolaryngol (2013) 1.01

Epidermal growth factor receptor expression in anal canal carcinoma. Am J Clin Pathol (2005) 1.01

Neuroendocrine neoplasms of the head and neck: some suggestions for the new WHO classification of head and neck tumors. Head Neck Pathol (2014) 1.00

Seromucinous hamartomas: a clinicopathological study of a sinonasal glandular lesion lacking myoepithelial cells. Histopathology (2009) 1.00

Gangliocytic paraganglioma: a rare case with metastases of all 3 elements to liver and lymph nodes. Ann Diagn Pathol (2010) 0.99

Molecular assessment of allelic loss in Warthin tumors. Mod Pathol (2005) 0.99

Cytokeratins 7 and 20 immunoexpression profile in goblet cell and classical carcinoids of appendix. Endocr Pathol (2007) 0.99

Malignant mixed tumors of the salivary gland: a study of loss of heterozygosity in tumor suppressor genes. Mod Pathol (2006) 0.98

Tumor-to-tumor metastases to follicular variant of papillary thyroid carcinoma: histologic, immunohistochemical, and molecular studies of two unusual cases. Endocr Pathol (2009) 0.98

Dieulafoy disease of the colon. Arch Pathol Lab Med (2009) 0.98

Ewing's family of tumors of the sinonasal tract and maxillary bone. Head Neck Pathol (2010) 0.97

PIK3CA mutations and PTEN loss in salivary duct carcinomas. Am J Surg Pathol (2013) 0.97